KUMDEE, C.; YADEE, J.; PANTUMONGKOL, W.; HADNORNTUN, P.; KITTIRATCHAKUL, N.; LEELAHAVARONG, P.; SUCHONWANICH, N.; EKAKKARARUNGROJ, C. Consequences and Enablers of the Selection of High-Cost Medicines to the National List of Essential Medicines Category E(2). Journal of Health Systems Research, Nonthaburi, Thailand, v. 15, n. 4, p. 456–476, 2021. Disponível em: https://he04.tci-thaijo.org/index.php/j_hsr/article/view/3300. Acesso em: 12 jul. 2025.